Literature DB >> 26802119

Cystic fibrosis and the war for iron at the host-pathogen battlefront.

Nicole M Bouvier1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26802119      PMCID： PMC4760826          DOI： 10.1073/pnas.1525101113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

Review 1.  Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Authors:  Karen A Robinson; Olaide A Odelola; Ian J Saldanha
Journal:  Cochrane Database Syst Rev       Date:  2014-05-22

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.

Authors:  Matthew R Hendricks; Lauren P Lashua; Douglas K Fischer; Becca A Flitter; Katherine M Eichinger; Joan E Durbin; Saumendra N Sarkar; Carolyn B Coyne; Kerry M Empey; Jennifer M Bomberger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

Review 4.  Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors:  Bridget Stuart; Jenny H Lin; Peter J Mogayzel
Journal:  Paediatr Respir Rev       Date:  2010-06-16       Impact factor: 2.726

Review 5.  Insights into the interaction between influenza virus and pneumococcus.

Authors:  Jonathan A McCullers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

6.  Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice.

Authors:  Angélica M M de Vrankrijker; Tom F W Wolfs; Oana Ciofu; Niels Høiby; Cornelis K van der Ent; Steen S Poulsen; Helle Krogh Johansen
Journal:  J Med Virol       Date:  2009-12       Impact factor: 2.327

7.  RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells.

Authors:  Bart E Van Ewijk; Tom F W Wolfs; Piet C Aerts; Kok P M Van Kessel; Andre Fleer; Jan L L Kimpen; Cornelis K Van der Ent
Journal:  Pediatr Res       Date:  2007-04       Impact factor: 3.756

Review 8.  Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas.

Authors:  Marie-Luise Brennan; Iris Schrijver
Journal:  J Mol Diagn       Date:  2015-11-26       Impact factor: 5.568

Review 9.  Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management.

Authors:  Margaret Rosenfeld; Bonnie W Ramsey; Ronald L Gibson
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

10.  Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.

Authors:  Melanie Chin; Maya De Zoysa; Robert Slinger; Ena Gaudet; Katherine L Vandemheen; Francis Chan; Lucie Hyde; Thien-Fah Mah; Wendy Ferris; Ranjeeta Mallick; Shawn D Aaron
Journal:  J Cyst Fibros       Date:  2014-12-18       Impact factor: 5.482
View more
  3 in total

Review 1.  Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections.

Authors:  Angela T Nguyen; Amanda G Oglesby-Sherrouse
Journal:  Appl Microbiol Biotechnol       Date:  2016-05-28       Impact factor: 4.813

2.  Killing of Pseudomonas aeruginosa by Chicken Cathelicidin-2 Is Immunogenically Silent, Preventing Lung Inflammation In Vivo.

Authors:  Maarten Coorens; Brandon J H Banaschewski; Brandon J Baer; Cory Yamashita; Albert van Dijk; Henk P Haagsman; Ruud A W Veldhuizen; Edwin J A Veldhuizen
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

3.  Cystic Fibrosis Isolates of Pseudomonas aeruginosa Retain Iron-Regulated Antimicrobial Activity against Staphylococcus aureus through the Action of Multiple Alkylquinolones.

Authors:  Angela T Nguyen; Jace W Jones; Miguel Cámara; Paul Williams; Maureen A Kane; Amanda G Oglesby-Sherrouse
Journal:  Front Microbiol       Date:  2016-07-27       Impact factor: 5.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.